🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled phase ...
Status
Completed
Location
Beijing Chao-Yang Hospital, Capital Medical University
Start Date
2021-02-24
Trial ID
NCT04805411
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
Background: One way to treat liver cancer is to deliver chemotherapy drugs...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-10-24
Trial ID
NCT05286814
Treatments Being Tested
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of HR1803...
Status
Completed
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2022-06-13
Trial ID
NCT05376904
Treatments Being Tested
This is a Phase 1, open-label, randomized, PK and safety study in a maximum...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2018-11-26
Trial ID
NCT03691584
Treatments Being Tested
Considerable progress in the treatment of metastatic melanoma has been made...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-10
Trial ID
NCT02619058
Treatments Being Tested
This study is composed of two stages: Part A initial dose escalation and Pa...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-01-04
Trial ID
NCT04651348
Treatments Being Tested
The purpose of this Phase I/II study is to determine the safety and effecti...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2022-03-03
Trial ID
NCT05036226
Treatments Being Tested